Bioabsorbable Stents Market PPT: Demand, Trends and Business Opportunities 2023-28

1
Global Bioabsorbable Stents Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Bioabsorbable Stents Market Research
Report The latest report by IMARC, titled
Bioabsorbable Stents Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 " finds that the global
bioabsorbable stents market size reached US
379.1 Million in 2022. Bioabsorbable stents
(BRS) are advanced medical tools coated with an
antiproliferative drug or gene that dissolves to
restore vessel patency. It regulates the blood
flow at branch points and limits the amount of
blood to areas of the vascular network while also
maintaining the flow. In addition, it reduces
vessel irritation and inflammation, improves
lesion imaging with cardiac computed tomography
(CT), and facilitates repeat treatments to the
same site. As a result, BRS is widely utilized in
hospitals and cardiac centers across the
globe. Request Free Sample Report
https//www.imarcgroup.com/bioabsorbable-stents-ma
rket/requestsample
4
Report Description and Highlights
Report Description

Global Bioabsorbable Stents Market Trends The
market is primarily driven by the growing
prevalence of cardiovascular diseases caused by
physical inactivity and excessive tobacco and
alcohol consumption. In addition, the increasing
preference for minimally invasive (MI)
procedures, as they offer less postoperative
pain, fewer complications, shortened hospital
stay, and faster recovery times, is contributing
to the market growth. Apart from this, the
leading market players are conducting research
and development (RD) activities to introduce
SLENDER integrated delivery system (IDS),
fixed-wire, and DIRECT RX bioabsorbable
rapid-exchange drug-eluting stent (DES) systems
to treat coronary artery disease. This, coupled
with the increasing utilization of percutaneous
coronary intervention (PCI) procedures for
opening a blocked artery and carrying oxygen-rich
blood through the body, is creating a positive
market outlook across the globe. Looking forward,
IMARC Group expects the market value to reach US
620.2 Million by 2028, exhibiting a CAGR of 8
during the forecast period (2023-2028). Looking
forward, the market value is projected to reach a
strong growth during the forecast period
(2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Biomaterial
Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents
Breakup by Absorption Rate
Slow-Absorption Stents Fast-Absorption S
tents Breakup by Application Coronary
Artery Disease Peripheral Artery Disease
Breakup by End User Hospitals
Cardiac Centers Breakup by Region N
orth America

6
Report Description and Highlights
Report Description
United States
Canada Asia-Pacific
China Japan
India South Korea
Australia Indo
nesia Others Europe
Germany France
United Kingdom
Italy Spain
Russia Others
Latin America

7
Report Description and Highlights
Report Description
Brazil Mexico
Others Middle East and
Africa


8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abbott Laboratories Arterius Limited B. Braun SE B
  iotronik SE Co. KG Boston Scientific Corporation
  Elixir Medical Corporation Kyoto Medical
  Planning Co. Ltd. Lepu Medical Technology (Beijing
  ) Co. Ltd. Meril Life Sciences Pvt. Ltd. Reva Medi
  cal LLC Terumo Corporation
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/bioabsorbable-stents-ma
  rket

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us